Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 125,000,000
    Countries
    Sector(s)
    Germany : € 125,000,000
    Industry : € 125,000,000
    Signature date(s)
    8/03/2013 : € 125,000,000

    Summary sheet

    Release date
    12 October 2012
    Status
    Reference
    Signed | 08/03/2013
    20120377
    Project name
    Promoter - financial intermediary
    HEALTH & NUTRITION FINE CHEM R&D
    Private company
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 125 million
    EUR 250 million
    Location
    Sector(s)
    Description
    Objectives

    The project concerns financing of research and development (R&D) activities relating to innovative new products, among others in the areas of skin care and healthy nutrition.

    The project aims to encourage research and technological development, as defined in Article 163 of the EC Treaty, and with the “Common Interest” criterion retained for the Treaty’s Article 267 point (c), i.e. the Bank’s financing activities under Knowledge Economy (i2i), (i) research and development and (ii) innovation.

    Environmental aspects
    Procurement

    R&D activities included in the project will not materially change current practice and will be carried out within existing facilities and laboratories, pilot plants, clinical centres, etc. An Environmental Impact Assessment (EIA) by a competent authority according to the Directive 2011/92/EU should not be required. This, along with any other environmental details, will be verified during the appraisal.

    The promoter is a private company not operating in the utilities sector, and is thus not covered by EU Directives on procurement.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - SYMRISE HEALTH&NUTRITION FINE CHEM R&D
    Publication Date
    10 Mar 2016
    Document language
    Main Topic
    Lending
    Document Number
    65176442
    Document Focus
    Environmental Information
    Project Number
    20120377
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now
    Environmental and Social Completion Sheet (ESCS) - SYMRISE HEALTH&NUTRITION FINE CHEM R&D
    Publication Date
    14 Nov 2018
    Document language
    Main Topic
    Lending
    Document Number
    80036615
    Document Focus
    Environmental Information
    Project Number
    20120377
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

    Related publications